ASH: Sanofi's BTK inhibitor raises platelet levels in 23% of ITP patients in phase 3 05.11.2024 21:16 Fiercebiotech.com ASH: Sanofi's BTK inhibitor raises platelet levels in 23% of ITP patients in phase 3 dincorvaia Tue, 11/05/2024 - 13:16
